# OnCo record intratumoral-immunotherapy (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/intratumoral-immunotherapy/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "intratumoral-immunotherapy" ;
  schema:name "Intratumoral immunotherapy"@en ;
  schema:alternateName "Intratumoural immunotherapy"@en, "Intralesional immunotherapy"@en ;
  schema:description "Intratumoral immunotherapy delivers an immune-directed treatment within a tumour. Local effects, immune responses and control of other lesions need separate evidence."@en ;
  schema:url <https://onco.cc/terms/intratumoral-immunotherapy/> ;
  schema:dateModified "2026-11-12"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/30295695/>, <https://pubmed.ncbi.nlm.nih.gov/30962585/>, <https://clinicaltrials.gov/study/NCT01976585>, <https://www.fda.gov/media/94129/download>, <https://pubmed.ncbi.nlm.nih.gov/28678778/>, <https://pubmed.ncbi.nlm.nih.gov/19029422/> ;
  onco:related <https://onco.cc/technologies/in-situ-vaccination/>, <https://onco.cc/technologies/oncolytic-virus/>, <https://onco.cc/drugs/talimogene-laherparepvec/>, <https://onco.cc/terms/itrecist/>, <https://onco.cc/terms/abscopal-effect/>, <https://onco.cc/technologies/cytokine-therapy/>, <https://onco.cc/terms/vaccine-adjuvants/>, <https://onco.cc/technologies/checkpoint-inhibitor/> .
